Prevalence of rheumatic disease in Colombia according to the Colombian Rheumatology Association (COPCORD) strategy. Prevalence study of rheumatic disease in Colombian population older than 18 years

Londoño, John; Ballestas, Ingris Peláez; Cuervo, Francy; Angarita, Ignacio; Giraldo, Rodrigo; Rueda, Juan C.; Ballesteros, Jesús G.; Baquero, Roberto; Forero, Elías; Cardiel, Mario H.; Saldarriaga, Eugenia-Lucía; Vásquez, Andrés; Arias, Sofía; Valero, Lina; González, Camilo; Ramírez, Javier; Toro, Carlos; Santos, Ana Maria Ribeiro dos

doi:10.1016/j.rcreue.2018.08.003

Cited by 17 publications

(14 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Following manual review, 41 publications were selected for inclusion. Eleven publications estimated the prevalence of SpA in Latin American countries (Table 1) [6][7][8][9][10][11][12][13][14][15][16]. Thirty-one publications reported demographic or clinical characteristics (Tables 2 and 3) [12,.…”

Section: Studies Included In the Analysismentioning

confidence: 99%

See 1 more Smart Citation

Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

et al. 2021

View full text Add to dashboard Cite

Large epidemiologic and clinical estimates of spondyloarthritis (SpA) in Latin America are not available. In this narrative review, our goal was to descriptively summarize the prevalence and features of SpA in Latin America, based on available small studies. A review of peer-reviewed literature identified 41 relevant publications. Of these, 11 (mostly based on Mexican data) estimated the prevalence of SpA and its subtypes, which varied from 0.28 to 0.9% (SpA), 0.02 to 0.8% (ankylosing spondylitis), 0.2 to 0.9% (axial SpA), and 0.004 to 0.08% (psoriatic arthritis). Demographic and/or clinical characteristics were reported in 31 of the 41 publications, deriving data from 3 multinational studies, as well as individual studies from Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, Peru, Uruguay, and Venezuela. Data relating to treatment, disease manifestations (articular and extra-articular), and comorbidities were summarized across the countries. Available data suggest that there is a variability in prevalence, manifestations, and comorbidities of SpA across Latin America. Basic epidemiologic and clinical data are required from several countries not currently represented. Data relating to current treatment approaches, patient outcomes, and socioeconomic impact within this large geographic region are also needed.

show abstract

Section: Studies Included In the Analysismentioning

confidence: 99%

“…Latin American prevalence estimates were summarized from epidemiology studies conducted in Mexico [9][10][11][12][13][14][15], Colombia [6,7], Cuba [8], and Venezuela [16], and ranged from 0.28 to 0.9% (SpA), 0.02 to 0.8% (AS), 0.2 to 0.9% (axSpA), and 0.004 to 0.08% (PsA) ( Table 1).…”

Section: Prevalence Of Spamentioning

confidence: 99%

Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The COPCORD study included 2336 surveys from Bogotá, 1220 each from Medellin and Cali, 746 from Barranquilla, and 503 each from Bucaramanga and Cúcuta [30]. As in other studies, the northern Caribbean region of Colombia, represented in our study by Barranquilla, was the most affected [34,40–42].…”

Section: Discussionmentioning

confidence: 92%

“…The third stage concerned the homes in each block; all household members were surveyed. The sample size was calculated at 6528 individuals for a 1.5 sampling design effect and 14% sampling error [30].…”

Section: Methodsmentioning

confidence: 99%

Demographic and clinical characteristics of chikungunya patients from six Colombian cities, 2014–2015

Rueda

Santos

Angarita

et al. 2019

Emerging Microbes & Infections

Self Cite

View full text Add to dashboard Cite

In 2014, the chikungunya virus reached Colombia for the first time, resulting in a nationwide epidemic. The objective of this study was to describe the demographics and clinical characteristics of suspected chikungunya cases. Chikungunya infection was confirmed by enzyme-linked immunosorbent assay and 548 patients where included in the study. Of these patients, 295 were positive for antibodies against chikungunya (53.8%), and 27.6% (151/295) were symptomatic for chikungunya infection, with a symptomatic:asymptomatic ratio of 1.04:1. Factors associated with infection included low income and low socio-economic strata (odds ratio [OR]: 1.8; 95% confidence interval [CI]: 1.0–3.2, p = 0.003 and OR: 2.1; CI: 1.3–3.4, p = 0.002, respectively). Confirmed symptomatic cases were associated with symmetric arthritis (OR: 11.7; CI: 6.0–23.0, p < 0.001) of ankles (OR: 8.5; CI: 3.5–20.9, p < 0.001), hands (OR: 8.5; CI: 3.5–20.9, p < 0.001), feet (OR: 6.5; CI: 2.8–15.3, p < 0.001), and wrists (OR: 17.3; CI: 2.3–130.5, p < 0.001). Our study showed that poverty is associated with chikungunya infection. Public health strategies to prevent and control chikungunya should focus on poorer communities that are more vulnerable to infection. The rate of asymptomatic infections among confirmed cases was 48.8%. However, those with symptoms displayed a characteristic rheumatic clinical picture, which could help differentiate chikungunya infection from other endemic viral diseases.

show abstract

“…In Colombia, according to the COPCORD - Colombian Association of Rheumatology registry, the prevalence is 0.02%. The peak of presentation is approximately 30 to 50 years[ 21 ]. This entity is more frequent in women with respect to men with a 5:1 ratio, and it affects Afro-descendants, highlighting the earlier presentation in life and the dcSSc subtype, with the latter having a worse prognosis in the evolution of the disease[ 15 , 21 ].…”

Section: Epidemiology Of Sscmentioning

confidence: 99%

Gastrointestinal manifestations of systemic sclerosis: An updated review

Lúquez-Mindiola

Atuesta

Aldana

2021

WJCC

View full text Add to dashboard Cite

Systemic sclerosis is an autoimmune disease characterized by vascular disease, fibrosis of the skin, and internal organ dysfunction. Gastrointestinal involvement is the most frequent complication of internal organs, impacting up to 90% of patients. Gastrointestinal involvement can affect any region of the gastrointestinal tract from the mouth to the anus, with a predominance of disorders being observed at the level of the upper digestive tract. The gastrointestinal involvement primarily involves the esophagus, small bowel, and rectum. The severity of gastrointestinal involvement affects quality of life and is a marker of worse prognosis and mortality in these patients. In this review, we describe the current findings regarding gastrointestinal involvement by this entity.

show abstract

Prevalence of rheumatic disease in Colombia according to the Colombian Rheumatology Association (COPCORD) strategy. Prevalence study of rheumatic disease in Colombian population older than 18 years

Cited by 17 publications

References 30 publications

Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

Demographic and clinical characteristics of chikungunya patients from six Colombian cities, 2014–2015

Gastrointestinal manifestations of systemic sclerosis: An updated review

Contact Info

Product

Resources

About